The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
983
September 13, 1996
View Complete Issue         Table of Contents 2019 
Cefepime (Maxipime) - A New Parenteral Cephalosporin
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Cefepime (Maxipime) - A New Parenteral Cephalosporin
September 13, 1996 (Issue: 983)
Cefepime hydrochloride (Maxipime - Bristol-Myers Squibb), a new 'fourth-generation' cephalosporin, has been approved by the US Food and Drug Administration (FDA) for parenteral treatment of urinary tract infections and skin and skin-structure ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Cefepime (Maxipime) - A New Parenteral Cephalosporin
Article code: 983b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.